Candel Therapeutics IncNASDAQ:CADL
- LAST PRICE6.1850
- TODAY'S CHANGE (%)-0.1150 (-1.8254%)
- Bid / Lots6.1700/ 4
- Ask / Lots6.2000/ 5
- Open / Previous Close6.1400 / 6.3000
- Day Range
- 52 Week Range
- Volume307,973
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CADL |
|---|---|---|
| 09:32 ET | 13537 | 6.14 |
| 09:34 ET | 3324 | 6.26 |
| 09:36 ET | 500 | 6.27 |
| 09:38 ET | 300 | 6.27 |
| 09:39 ET | 500 | 6.2 |
| 09:41 ET | 200 | 6.23 |
| 09:43 ET | 4460 | 6.34 |
| 09:45 ET | 3389 | 6.42 |
| 09:48 ET | 1431 | 6.42 |
| 09:50 ET | 1319 | 6.4 |
| 09:52 ET | 2316 | 6.39 |
| 09:54 ET | 5750 | 6.44 |
| 09:57 ET | 5400 | 6.455 |
| 09:59 ET | 3200 | 6.43 |
| 10:01 ET | 2475 | 6.455 |
| 10:03 ET | 6300 | 6.47 |
| 10:06 ET | 2100 | 6.495 |
| 10:08 ET | 1100 | 6.5387 |
| 10:10 ET | 100 | 6.54 |
| 10:12 ET | 4609 | 6.425 |
| 10:14 ET | 2180 | 6.43 |
| 10:17 ET | 5594 | 6.385 |
| 10:24 ET | 2233 | 6.39 |
| 10:28 ET | 5565 | 6.45 |
| 10:32 ET | 4046 | 6.46 |
| 10:33 ET | 3903 | 6.46 |
| 10:37 ET | 933 | 6.4223 |
| 10:39 ET | 100 | 6.465 |
| 10:44 ET | 1303 | 6.445 |
| 10:46 ET | 400 | 6.47 |
| 10:48 ET | 350 | 6.45 |
| 10:50 ET | 300 | 6.45 |
| 10:51 ET | 100 | 6.45 |
| 10:53 ET | 6083 | 6.46 |
| 10:55 ET | 300 | 6.445 |
| 11:00 ET | 500 | 6.4436 |
| 11:02 ET | 100 | 6.46 |
| 11:04 ET | 650 | 6.47 |
| 11:06 ET | 600 | 6.445 |
| 11:08 ET | 3405 | 6.41 |
| 11:09 ET | 100 | 6.395 |
| 11:11 ET | 100 | 6.385 |
| 11:15 ET | 200 | 6.38 |
| 11:18 ET | 4700 | 6.415 |
| 11:20 ET | 1736 | 6.415 |
| 11:22 ET | 450 | 6.415 |
| 11:24 ET | 300 | 6.415 |
| 11:26 ET | 200 | 6.415 |
| 11:27 ET | 4150 | 6.385 |
| 11:29 ET | 100 | 6.38 |
| 11:31 ET | 600 | 6.38 |
| 11:33 ET | 1200 | 6.36 |
| 11:36 ET | 3300 | 6.34 |
| 11:38 ET | 200 | 6.34 |
| 11:40 ET | 100 | 6.33 |
| 11:42 ET | 2087 | 6.33 |
| 11:44 ET | 1200 | 6.3 |
| 11:45 ET | 100 | 6.28 |
| 11:47 ET | 950 | 6.285 |
| 11:49 ET | 300 | 6.285 |
| 11:51 ET | 110 | 6.27 |
| 11:54 ET | 300 | 6.285 |
| 11:56 ET | 200 | 6.28 |
| 11:58 ET | 2200 | 6.285 |
| 12:00 ET | 600 | 6.28 |
| 12:02 ET | 4806 | 6.23 |
| 12:03 ET | 952 | 6.25 |
| 12:05 ET | 425 | 6.22 |
| 12:07 ET | 1300 | 6.24 |
| 12:09 ET | 200 | 6.26 |
| 12:12 ET | 1538 | 6.31 |
| 12:14 ET | 450 | 6.31 |
| 12:16 ET | 1791 | 6.32 |
| 12:18 ET | 2500 | 6.34 |
| 12:20 ET | 600 | 6.385 |
| 12:21 ET | 1000 | 6.4099 |
| 12:23 ET | 200 | 6.4 |
| 12:25 ET | 770 | 6.4 |
| 12:27 ET | 300 | 6.38 |
| 12:30 ET | 2300 | 6.32 |
| 12:32 ET | 1200 | 6.34 |
| 12:34 ET | 100 | 6.32 |
| 12:36 ET | 300 | 6.31 |
| 12:39 ET | 4300 | 6.36 |
| 12:41 ET | 500 | 6.355 |
| 12:43 ET | 1844 | 6.36 |
| 12:45 ET | 1850 | 6.405 |
| 12:48 ET | 200 | 6.405 |
| 12:50 ET | 968 | 6.42 |
| 12:52 ET | 1100 | 6.43 |
| 12:54 ET | 3499 | 6.37 |
| 12:57 ET | 1000 | 6.37 |
| 01:03 ET | 100 | 6.365 |
| 01:08 ET | 200 | 6.39 |
| 01:12 ET | 100 | 6.38 |
| 01:15 ET | 100 | 6.38 |
| 01:17 ET | 1200 | 6.365 |
| 01:19 ET | 6955 | 6.315 |
| 01:21 ET | 482 | 6.34 |
| 01:24 ET | 6774 | 6.3 |
| 01:26 ET | 3156 | 6.325 |
| 01:28 ET | 1449 | 6.3 |
| 01:30 ET | 3701 | 6.23 |
| 01:32 ET | 503 | 6.24 |
| 01:33 ET | 500 | 6.22 |
| 01:37 ET | 222 | 6.21 |
| 01:39 ET | 550 | 6.23 |
| 01:42 ET | 1100 | 6.255 |
| 01:44 ET | 489 | 6.3 |
| 01:46 ET | 740 | 6.2885 |
| 01:50 ET | 100 | 6.29 |
| 01:53 ET | 217 | 6.3 |
| 01:57 ET | 800 | 6.31 |
| 02:02 ET | 9288 | 6.23 |
| 02:06 ET | 100 | 6.2 |
| 02:09 ET | 250 | 6.215 |
| 02:18 ET | 2200 | 6.2 |
| 02:20 ET | 1547 | 6.185 |
Jun 18, 2024
Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference, from 8:00AM ET on Tuesday Jun 18, 2024 by Dow Jones
8:00AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 11, 2024
Candel Therapeutics to Join Russell 3000(R) Index, from 8:00AM ET on Tuesday Jun 11, 2024 by Dow Jones
8:00AM ET on Tuesday Jun 11, 2024 by Dow Jones
Jun 3, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Candel Therapeutics Inc | 187.5M | -4.8x | --- |
Pyxis Oncology Inc | 188.4M | -2.1x | --- |
Design Therapeutics Inc | 183.6M | -3.1x | --- |
Rani Therapeutics Holdings Inc | 192.6M | -3.0x | --- |
Aldeyra Therapeutics Inc | 193.1M | -6.2x | --- |
Acrivon Therapeutics Inc | 180.9M | -2.1x | --- |
Company Information
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is in ongoing clinical trials in non-small cell lung cancer (NSCLC), borderline resectable pancreatic cancer, and localized, non-metastatic prostate cancer. CAN-3110 is the lead product candidate from the HSV platform and is in an ongoing investigator-sponsored phase I clinical trial in recurrent high-grade glioma (HGG). Its enLIGHTEN Discovery Platform leverages human biology and advanced analytics to create new viral immunotherapies for solid tumors.
Contact Information
- Headquarters
- 117 Kendrick Street,, Suite 450NEEDHAM, MA, United States 02494
- Phone
- 617-916-5445
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Paul Manning
- President, Chief Executive Officer, Director
- Paul Tak
- Interim Chief Financial Officer
- Charles Schoch
- Chief Scientific Officer
- Francesca Barone
- Vice President - Development Leader
- Christopher Matheny
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $187.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 29.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.29 |
Book Value | $0.44 |
P/E Ratio | -4.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
